Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease

American Journal of Nephrology

Volumn 20, Issue 1, 2000, Pages 32-36

  Nakamura, Tsukasa ^a   Ushiyama, Chifuyu ^a   Suzuki, Shingo ^a   Ebihara, Isao ^b   Shimada, Noriaki ^b   Koide, Hikaru ^b  

^a Misato Junshin Hospital   (Japan)

^b KOTO HOSPITAL   (Japan)

Author keywords

Extracellular matrix; Metalloproteinase; Polycystic kidney; Tissue inhibitor of metalloproteinase

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME IMMUNOASSAY; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; MALE; PRIORITY JOURNAL;

EID: 0033957602     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013552     Document Type: Article

References (30)

1. Martinez-Hernandez A, Amenta PS: The basement membrane in pathology. Lab Invest 1983;48:656-677.
2. Carome FA, Bacallao R, Kanwar YS: Biology of polycystic kidney disease. Lab Invest 1994; 70:437-448.
3. Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Nagao S, Takahashi H, Koide H: Growth factor gene expression in kidney of murine polycystic kidney disease. J Am Soc Nephrol 1993; 3:1378-1386.
4. Ebihara I, Nakamura T, Takahashi T, Yamamoto M, Tomino Y, Nagao S, Takahashi H, Koide H: Altered extracellular matrix component gene expression in murine polycystic kidney. Renal Physiol Biochem 1995;18:73-80.
5. Norman JT, Lewis MP: Matrix metalloproteinase (MMPs) in renal fibrosis. Kidney Int 1996;49:S61-S63.
6. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV-40 transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-17221.
7. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, Zucker S: Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 1992;28:213-230.
8. Akiyama K, Shikata K, Sugimoto H, Matsuda M, Shikata Y, Fujimoto N, Obata K, Matsui H, Makino H: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997;95: 115-128.
9. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase-9 using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
10. Torii A, Kodera Y, Uesaka K, Hirai T, Yasui K, Morimoto T, Yamamura Y, Kato T, Hayakawa T, Fujimoto N, Kito T: Matrix metalloproteinase-9 in human plasma has 96% specificity and 56% sensitivity for gastric cancer screening. Int J Clin Oncol 1996;1:39-43.
11. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 using monoclonal antibodies. Clin Chim Acta 1993;219:1-14.
12. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-108.
13. Grantham JJ: Mechanisms of progression in autosomal dominant polycystic kidney diseases. Kidney Int 1997;52(suppl 63):93-97.
14. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Ncphrol 1994;13:1349-1354.
15. Fick GM, Gabow PA: Hereditary and acquired cystic disease of the kidney. Kidney Int 1994; 46:951-964.
16. Nakamura T, Fukui M, Ebihara I, Tomino Y, Koide H: Low protein diet blunts the rise in glomerular gene expression in focal glomerulonephritis. Kidney Int 1994;45:1593-1605.
17. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Abnormal gene expression of matrix MMPs and their inhibitor in glomeruli of diabetic rats. Renal Physiol Biochem 1994;17:316-328.
18. Ebihara I, Nakamura T, Tomino Y, Koide H: Effect of a specific endothelin receptor A antagonist or angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 1997;12:1001-1006.
19. Gabow PA: Polycystic kidney disease: Clues to pathogenesis. Kidney Int 1991;40:989-996.
20. Norman JT, Gatti L, Wilson PD, Lewis M: Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in normal kidney and in fibrosis. Exp Nephrol 1995;3:88-89.
21. Garner KD, Burnside JS, Elzinga LW, Locksley RM: Cytokines in fluids from polycystic kidneys. Kidney Int 1991;39:718-724.
22. Rankin CA, Suzuki K, Itoh Y, Ziemer DM, Grantham JJ, Calvet JP, Nagase H: Matrix metalloproteinases and TIMPs in cultured C57BL/6L-cpk kidney tubules. Kidney Int 1996;50:835-844.
23. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y, Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinase-1 levels in patients with liver diseases. J Gastroenterol Hepatol 1993;8:437-441.
24. r 92,000 type IV collagenase is increased in plasma of patients with colon and breast cancer. Cancer Res 1993;53:140-146.
25. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon C, Gault MH: Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 1984;26:190-193.
26. Watson ML: Hypertension in polycystic disease; in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, Oxford Press, 1996, pp 407-429.
27. Ebihara I, Nakamura T, Ushiyama C, Suzuki S, Shimada N, Koide H: Effect of oral adsorbent AST-120 on plasma MMP-9 and serum TIMP-1 concentrations in chronic renal failure. Nephron 1999;83:169.
28. Grimm PC, Crocker JFS, Malatjabian F, Ogborn MR: The microanatomy of the intrahepatic bile duct in polycystic disease: Comparison of the cpk mouse and human. J Exp Pathol 1990;71:119-131.
29. Everson GT, Emmett M, Brown WR, Redmond P, Thickman D: Functional similarities of hepatic cystic and biliary epithelium. Studies of fluid constituents and in vivo secretion in response to secretion. Hepatology 1990;11: 557-565.
30. Fukuda S, Imoto M, Koyama Y, Miyazawa Y, Nakano I, Hattori M, Urano F, Kodama S, Iwata K, Hayakawa T: Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Jpn Soc Gastroenterol 1991;26:37-41.